华尔街顶级分析师对这些顶尖公司改变了他们的展望。有关所有分析师评级变动的完整视图，包括上调、下调和首次评级，请查看我们的 分析师评级页面。
<ul>
<li>BTIG 分析师 Julian Harrison 将 Outlook Therapeutics Inc (NASDAQ: OTLK) 的评级从买入下调至中性。Outlook Therapeutics 的股票周五收于 $0.23。查看其他分析师对该股票的看法。</li>
<li>摩根士丹利分析师 Shane Brett 将 Applied Materials Inc (NASDAQ: AMAT) 的评级从超配下调至等权，并宣布目标价为 $502。Applied Materials 的股票周五收于 $436.62。查看其他分析师对该股票的看法。</li>
<li>DA Davidson 分析师 Gil Luria 将 CoreWeave Inc (NASDAQ: CRWV) 的评级从买入下调至中性，并将目标价从 $175 下调至 $100。CoreWeave 的股票周五收于 $107.30。查看其他分析师对该股票的看法。</li>
<li>Leerink Partners 分析师 Andrew Berens 将 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) 的评级从跑赢大盘下调至市场表现，并将目标价从 $792 大幅下调至 $641。Regeneron Pharmaceuticals 的股票周五收于 $698.25。查看其他分析师对该股票的看法。</li>
<li>DA Davidson 分析师 Clark Wright 将 LiveRamp Holdings (NYSE: RAMP) 的评级从买入下调至中性，并将目标价从 $35 上调至 $38.5。LiveRamp 的股票周五收于 $29.66。查看其他分析师对该股票的看法。</li>
</ul>
考虑购买 CRWV 股票吗？以下是分析师的看法：

图片来源于 Shutterstock

再生元制药

RAMP

CRWV

OTLK

动态半导体 ETF - Invesco

半导体 ETF - VanEck Vectors

标普半导体 ETF - SPDR

华尔街分析师已将多只股票评级下调，包括应用材料公司（Applied Materials, AMAT），其评级从 “增持” 下调至 “持平”，目标价为 502 美元。其他下调的股票包括 Outlook Therapeutics（OTLK）、CoreWeave（CRWV）、再生元制药（Regeneron Pharmaceuticals, REGN）和 LiveRamp Holdings（RAMP）。欲查看分析师评级变动的完整列表，请访问 Benzinga 的分析师评级页面

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
<div class="lb-trans">华尔街顶级分析师对这些顶尖公司改变了他们的展望。有关所有分析师评级变动的完整视图，包括上调、下调和首次评级，请查看我们的 分析师评级页面。
</div><ul>
<li>BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc (NASDAQ: OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.</li>
<li>Morgan Stanley analyst Shane Brett downgraded Applied Materials Inc (NASDAQ: AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how other analysts view this stock.</li>
<li>DA Davidson analyst Gil Luria downgraded CoreWeave Inc (NASDAQ: CRWV) from Buy to Neutral and cut the price target from $175 to $100. CoreWeave shares closed at $107.30 on Friday. See how other analysts view this stock.</li>
<li>Leerink Partners analyst Andrew Berens downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from Outperform to Market Perform and slashed the price target from $792 to $641. Regeneron Pharmaceuticals shares closed at $698.25 on Friday. See how other analysts view this stock.</li>
<li>DA Davidson analyst Clark Wright downgraded LiveRamp Holdings (NYSE: RAMP) from Buy to Neutral and raised the price target from $35 to $38.5. LiveRamp shares closed at $29.66 on Friday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>BTIG 分析师 Julian Harrison 将 Outlook Therapeutics Inc (NASDAQ: OTLK) 的评级从买入下调至中性。Outlook Therapeutics 的股票周五收于 $0.23。查看其他分析师对该股票的看法。</li>
<li>摩根士丹利分析师 Shane Brett 将 Applied Materials Inc (NASDAQ: AMAT) 的评级从超配下调至等权，并宣布目标价为 $502。Applied Materials 的股票周五收于 $436.62。查看其他分析师对该股票的看法。</li>
<li>DA Davidson 分析师 Gil Luria 将 CoreWeave Inc (NASDAQ: CRWV) 的评级从买入下调至中性，并将目标价从 $175 下调至 $100。CoreWeave 的股票周五收于 $107.30。查看其他分析师对该股票的看法。</li>
<li>Leerink Partners 分析师 Andrew Berens 将 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) 的评级从跑赢大盘下调至市场表现，并将目标价从 $792 大幅下调至 $641。Regeneron Pharmaceuticals 的股票周五收于 $698.25。查看其他分析师对该股票的看法。</li>
<li>DA Davidson 分析师 Clark Wright 将 LiveRamp Holdings (NYSE: RAMP) 的评级从买入下调至中性，并将目标价从 $35 上调至 $38.5。LiveRamp 的股票周五收于 $29.66。查看其他分析师对该股票的看法。</li>
</ul>
</div>Considering buying CRWV stock? Here’s what analysts think:
<div class="lb-trans">考虑购买 CRWV 股票吗？以下是分析师的看法：
</div>
<div class="lb-trans">
</div>Photo via Shutterstock
<div class="lb-trans">图片来源于 Shutterstock
</div>

This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

benzinga_article

LiveRamp

Coreweave

Outlook Therapeutics

应用材料

这位应用材料公司的分析师不再持乐观态度；以下是周一的五大降级